What are the causes of increased heamoglobin and how can we treat them

Reading File
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

erythrocytosis AND treatment

Searching the Web

Merck Manual erythrocytosis causes treatment secondary polycythemia

Reading File
Reading File
Reading Web Page

https://www.merckmanuals.com/professional/hematology/myelopr…

Increased haemoglobin (Hb) is called erythrocytosis or polycythaemia. It may reflect too little plasma fluid, or a true increase in red blood cells. The distinction matters because treatment depends on the cause.

Causes

1. Relative increase: dehydration

Red-cell mass is normal, but blood is concentrated due to reduced plasma volume.
  • Not drinking enough fluids
  • Vomiting or diarrhoea
  • Excessive sweating
  • Diuretic medicines
This is often temporary. Robbins Basic Pathology describes this as relative polycythaemia from reduced plasma volume. - Robbins & Kumar Basic Pathology, p. 398

2. Secondary erythrocytosis: the body responds to low oxygen or excess erythropoietin (EPO)

Low-oxygen causes
  • Smoking, including carbon monoxide exposure
  • Obstructive sleep apnoea
  • COPD or other chronic lung disease
  • Severe obesity-hypoventilation
  • Cyanotic congenital heart disease or right-to-left cardiac shunt
  • Living or prolonged stays at high altitude
Excess EPO production
  • Kidney disease, renal artery narrowing, renal cysts, or after kidney transplantation
  • Rare EPO-producing tumours, particularly renal-cell carcinoma, hepatocellular carcinoma, and cerebellar haemangioblastoma
  • Rare inherited high-oxygen-affinity haemoglobin variants
Medication or substance related
  • Testosterone or anabolic steroids
  • EPO injections or blood doping
  • SGLT2 inhibitors used for diabetes or heart/kidney disease
  • Some cancer drugs, including certain tyrosine-kinase inhibitors
The Merck evaluation guidance lists oxygen saturation, serum EPO, and P50 testing as key parts of investigating isolated erythrocytosis. - Robbins & Kumar Basic Pathology, p. 398

3. Primary erythrocytosis: polycythaemia vera (PV)

This is a bone-marrow blood cancer, usually driven by a JAK2 mutation. It can also raise white cells and platelets. Symptoms may include headaches, dizziness, blurred vision, itching after a hot bath, burning/red hands or feet, enlarged spleen, and blood clots.

How it is treated

CauseMain treatment
DehydrationRehydrate and treat vomiting, diarrhoea, or medication-related fluid loss. Repeat the blood count.
Smoking or carbon monoxideStop smoking and investigate possible carbon monoxide exposure.
Sleep apnoeaSleep assessment and CPAP if confirmed; weight management where relevant.
Lung or heart diseaseTreat the underlying condition. Long-term oxygen may be used when clinically indicated.
High altitudeUsually no treatment if temporary and asymptomatic; returns toward normal after descent/acclimatisation.
Testosterone, EPO, anabolic steroids, SGLT2 inhibitor, etc.Do not stop a prescribed drug on your own. The prescriber should review dose, need, alternatives, and monitoring.
Kidney disorder or EPO-producing tumourTreat the renal condition or tumour with the appropriate specialist team.
Polycythaemia veraHaematology care, blood removal (venesection/phlebotomy), usually low-dose aspirin if safe, and sometimes medicines to lower blood-cell production.
For secondary erythrocytosis, treatment is usually directed at the cause. Oxygen therapy can help hypoxia-related cases; venesection is generally reserved for significant symptoms of hyperviscosity or selected severe elevations, because the higher Hb may be compensating for chronic low oxygen. In PV, phlebotomy and medication are used to reduce clot risk, as summarized in the Merck PV overview.

What tests are commonly needed

A clinician will generally repeat the full blood count while well hydrated, then consider:
  • Oxygen saturation, sometimes blood gas or overnight sleep testing
  • Serum EPO level
  • JAK2 mutation testing if PV is suspected
  • Kidney and liver tests, urinalysis, and targeted imaging if indicated
  • Review of smoking, altitude exposure, supplements, testosterone, EPO, and medications

Seek urgent care now if

There is a high Hb/haematocrit plus possible clot symptoms: sudden weakness or facial droop, trouble speaking, chest pain, shortness of breath, coughing blood, one-sided leg swelling/pain, new severe headache, fainting, or visual loss.
A recent systematic review also highlights drug-induced erythrocytosis, especially with testosterone and SGLT2 inhibitors, as an important modern cause (Liu et al., 2025).

Hemoglobin more than 17 or 16 is mainly caused... Bye.

Reading File
Finding Sources
Searching PubMed

erythrocytosis AND diagnosis

Searching the Web

erythrocytosis common causes smoking sleep apnea testosterone dehydration clinical evaluation

If you mean haemoglobin above about 17 g/dL in men or 16 g/dL in women, it is most often due to a secondary or reversible cause, not necessarily polycythaemia vera.
The common causes are:
  1. Dehydration: a concentrated blood sample after poor fluid intake, vomiting, diarrhoea, sweating, or diuretics.
  2. Smoking or carbon monoxide exposure.
  3. Obstructive sleep apnoea, especially with snoring, witnessed pauses in breathing, or daytime sleepiness.
  4. Living at high altitude.
  5. Testosterone/anabolic steroids, EPO injections, and sometimes SGLT2 diabetes medicines.
  6. Chronic lung disease or certain heart diseases causing low oxygen.
Less commonly, it is from polycythaemia vera, a bone-marrow disorder. This is more likely if the elevation persists on repeat testing, or there are high platelets/white cells, itching after hot showers, unusual blood clots, enlarged spleen, or very low EPO levels.
A good first step is a repeat CBC when well hydrated, along with oxygen saturation and a review of smoking, sleep apnoea symptoms, altitude, and medicines. Persistent elevation should be evaluated by a clinician, often with EPO and JAK2 testing.
This is a shared conversation. Sign in to Orris to start your own chat.